Product1 distinct publisher3 min readPublished
The startup's genetic switch is aimed at the reliability problem that has kept engineered microbes from replacing synthetic nitrogen, and the proof sits two to three years out in corn trials that had not yet been harvested.
The Product Desk · Product desk

Compiled by The Product DeskSomething wrong?How this is made
In August, corn treated with Switch's microbes looked visibly healthier than untreated plants in the same trials [13]. Plant appearance in August is what a field day runs on. The plants were not due to be harvested until late October or early November [13], which puts two to three months between what a visitor can see and what a scale can weigh [19]. Schnabel says it is too early to tell exactly how well this works in the field [12], which is both correct and a good reason not to plan a nitrogen program around it.
It helps to separate the pitch from the work. Set the pitch, "we have to reinvent fertilizer" [4], next to the actual work, which is scheduling. You cannot apply enough microbes to reach the colonization level you want at the roots, because doing so is too expensive and logistically awkward, so you seed a smaller number and rely on them to divide and establish [9]. Making and releasing ammonia is energetically expensive for a microbe, and one that spends everything on it grows badly [7]. Dan Blaustein-Rejto of the Breakthrough Institute puts it from the cell's side: a microbe fixes nitrogen to build its own proteins and survive [8]. The genetic switch, a stretch of DNA that turns the ammonia genes on [5], exists to let the cell stay selfish long enough to become a population.
The soil-nitrogen trigger is where the grower's money sits. By that design, ammonia shows up only in ground that has already been left short, so the value only appears if the synthetic rate came down first [20]. Biologicals are sold as replacing some portion of synthetic nitrogen [17]; this one wants the subtraction before the evidence.
Then the timing. Industrial nitrogen is natural gas run through the Haber-Bosch process [15], and fertilizer production accounts for roughly 2% of global greenhouse-gas emissions [1]. Add the company's two to three years to the 2026 trial season and a commercial launch lands around 2028 or 2029 [18]. Expensive gas is the reason the cost case reads well now. Nothing in the biology requires gas to still be expensive then.
The test worth carrying into any biological-nitrogen meeting is to keep three claims apart and refuse to let one answer for another. Establishment: did a colony form in your soil, at your seeding rate, in your season. Production: did the switch actually turn on. Delivery: did the plant receive enough ammonia to cover the pounds of synthetic nitrogen you took out. Plot photographs speak to the first and hint at nothing beyond it. Yield against an untreated check is the only evidence that touches the third. Until someone measures the third, the safe way to buy a biological is on top of the existing program rather than instead of part of it, and that is exactly the purchase where a low-nitrogen trigger has no chance to earn its keep [20].
Ranked by verification strength, evidence, and original report placement.
Production of chemical fertilizer accounts for roughly 2% of global greenhouse-gas emissions.
MIT Technology Review reports that the Iran war has sent energy and fertilizer prices skyrocketing in recent months.
Switch Bioworks is taking an approach that essentially allows microbes to establish themselves and grow into healthy colonies before shifting into nitrogen-producing mode.
Tim Schnabel, founder and CEO of Switch Bioworks, says: "We have to reinvent fertilizer."
A genetic switch is a section or sections of DNA that controls how genes are turned on and off; in Switch's case it activates genes that trigger ammonia production in and release from the cell.
The leading option Switch is pursuing is to have the microbes react to the nitrogen level in the soil, beginning ammonia production once it drops to a certain level.
Distinct publishers with included, body-backed reporting in this cluster.
1 article · September 1, 2026
Follow any of these and your For You feed starts watching them — no settings page required.
science
Drought does not kill trees, it disarms them: 12.5 million Mississippi pines are the template1 distinct publisher
science
NC State's Socratic Challenger makes the AI cross-examine the student's research question1 distinct publisher
science
Nitrogen is the fragile link in the food chain, and the substitutes do not arrive in one season1 distinct publisher
science
India's cereal reform has the wrong target: aim at nitrogen, and the water follows1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Mechanism explained, results absent
The biology in this story is well grounded — the energy cost of fixation is stated by MIT Technology Review and independently restated by the Breakthrough Institute — but every fact specific to Switch Bioworks comes from its own founder, and the 2% emissions share and 90-million-acre corn figure arrive without a citation. The one performance observation is somebody looking at corn in August.
Trials for Switch, acres for the incumbent
Switch's presence in the world is six states of unharvested corn. The only real deployment evidence in this reporting belongs to Pivot Bio — millions of acres since 2011, and a product line that just grew past corn into cotton, wheat and small grains — which measures the category's traction, not the genetic switch's.
Caveats included, proof postponed
MIT Technology Review does much of the deflating itself: Schnabel's 'too early to tell' is in the piece, and Blaustein-Rejto's warning about the distance between vendor data and independent findings sits near the end. What still tilts this positive is the distance between the framing — reinventing fertilizer, cleaning up a hard-to-abate sector — and the evidence, which is one growing season that had not been weighed yet.
Mostly people who sell nitrogen alternatives
Two of the four voices have product to move: Switch's founder, describing a company three years from revenue, and Pivot Bio's CTO, who follows a description of squeezed grower margins with 'this next decade is when biologicals on the farm are going to go mainstream.' Blaustein-Rejto at the Breakthrough Institute and Havlin at North Carolina State have no such stake, and Blaustein-Rejto is the one who names the vendor-data problem out loud.
Single desk, single season
One publisher, one reporting pass, no documents, and the decisive data point — what the trial plots actually yielded — was scheduled to exist weeks after publication. The mechanism claims will likely hold; the performance and timeline claims should be treated as unverified until a harvest or an independent trial says otherwise.